Ozempic / GLP-1 Stomach Paralysis Litigation
In re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
Where it stands
Active MDL with a fast-growing case count as GLP-1 use expands; early case-management and bellwether selection phases. Claims proceed individually.
What it's about
Patients across the country are suing the makers of blockbuster GLP-1 weight-loss and diabetes drugs, alleging severe gastrointestinal injuries including stomach paralysis.
The allegations
Plaintiffs allege the drug makers failed to adequately warn that GLP-1 receptor agonists could cause gastroparesis and bowel obstruction, including after discontinuation.
Related cases
Hair Relaxer & Straightener Cancer Litigation
Active MDL with thousands of pending personal-injury cases
Thousands of women sue relaxer makers over links between chemical straighteners and hormone-driven cancers. Cases are consolidated in Chicago, with the first bellwether trials expected to shape any global resolution.
Social Media Adolescent Addiction Litigation
Fast-moving in 2026: Meta settled the state attorneys general claims on August 26, 2026 (reported ~$17.1B over ten years plus product changes)
Thousands of lawsuits by teens, families, and school districts claim social platforms engineered addictive products that harmed adolescent mental health. The states settled with Meta in August 2026; individual and school-district claims continue.